EUVIMEDEUVIMED entdecken
Crossref

Intestinal Candida albicans Exacerbates Allergic Asthma Via IL-17-Driven Neutrophilic Inflammation

Haotian Sun

Bioscience Biotechnology Research Communications · 25.03.2026 · 19 (1) · 12-18

DOI: 10.21786/bbrc/19.1.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience Biotechnology Research Communications, online erschienen am 30.03.2026. Verfasst von Haotian Sun.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The “gut-lung axis” plays a key role in asthma pathogenesis, yet the contribution of fungal components, particularly Candida albicans (CA), remains poorly understood. As a potent inducer of Th17/IL-17 responses, CA may promote neutrophilic inflammation associated with severe asthma. This study investigated whether intestinal CA colonization exacerbates allergic asthma via the IL-17 pathway, independent of classical Th2 immunity, and examined its impact on gut microbiota. C57BL/6 mice were pretreated with antibiotics, colonized with CA, and subjected to ovalbumin (OVA)-induced allergic asthma, with or without anti-IL-17A neutralizing antibody treatment. Airway hyperresponsiveness (AHR), bronchoalveolar lavage fluid (BALF) cytology, cytokine levels, lung histopathology, and gut microbiota composition were assessed. CA colonization significantly aggravated OVA-induced AHR, IgE production, and lung inflammation, shifting the pulmonary response toward a neutrophilic phenotype and elevating IL-17 levels without affecting Th2 cytokines. IL-17A blockade reversed these exacerbating effects and partially restored CA-induced alterations in gut bacterial microbiota structure. Collectively, these findings demonstrate that intestinal CA exacerbates allergic asthma via IL-17-driven neutrophilic inflammation—an effect reversed by IL-17 neutralization—and that CA-induced gut microbiota dysbiosis is partially restored upon IL-17 blockade, revealing a fungal-gut-lung axis and positioning IL-17 as a therapeutic target in severe asthma.

Zitieren

APA

Sun, H. (2026). Intestinal Candida albicans Exacerbates Allergic Asthma Via IL-17-Driven Neutrophilic Inflammation. Bioscience Biotechnology Research Communications, 19(1), 12-18. https://doi.org/10.21786/bbrc/19.1.2

Vancouver

Sun H. Intestinal Candida albicans Exacerbates Allergic Asthma Via IL-17-Driven Neutrophilic Inflammation. Bioscience Biotechnology Research Communications. 2026;19(1):12-18. doi:10.21786/bbrc/19.1.2

BibTeX
@article{Sun2026,
  author = {Sun, Haotian},
  title = {Intestinal Candida albicans Exacerbates Allergic Asthma Via IL-17-Driven Neutrophilic Inflammation},
  journal = {Bioscience Biotechnology Research Communications},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {12--18},
  doi = {10.21786/bbrc/19.1.2}
}
Kostenlos starten →